These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 11738867)

  • 21. Methylated DNA-binding domain 1 and methylpurine-DNA glycosylase link transcriptional repression and DNA repair in chromatin.
    Watanabe S; Ichimura T; Fujita N; Tsuruzoe S; Ohki I; Shirakawa M; Kawasuji M; Nakao M
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12859-64. PubMed ID: 14555760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional specificity of CpG DNA-binding CXXC domains in mixed lineage leukemia.
    Risner LE; Kuntimaddi A; Lokken AA; Achille NJ; Birch NW; Schoenfelt K; Bushweller JH; Zeleznik-Le NJ
    J Biol Chem; 2013 Oct; 288(41):29901-10. PubMed ID: 23990460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells.
    Koizume S; Tachibana K; Sekiya T; Hirohashi S; Shiraishi M
    Nucleic Acids Res; 2002 Nov; 30(21):4770-80. PubMed ID: 12409468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific binding of the methyl binding domain protein 2 at the BRCA1-NBR2 locus.
    Auriol E; Billard LM; Magdinier F; Dante R
    Nucleic Acids Res; 2005; 33(13):4243-54. PubMed ID: 16052033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. hMLH1 promoter methylation and silencing in primary endometrial cancers are associated with specific alterations in MBDs occupancy and histone modifications.
    Xiong Y; Dowdy SC; Eberhardt NL; Podratz KC; Jiang SW
    Gynecol Oncol; 2006 Oct; 103(1):321-8. PubMed ID: 16701802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties.
    Fraga MF; Ballestar E; Montoya G; Taysavang P; Wade PA; Esteller M
    Nucleic Acids Res; 2003 Mar; 31(6):1765-74. PubMed ID: 12626718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Profiling methyl-CpG specific determinants on transcriptionally silent chromatin.
    El-Osta A; Baker EK; Wolffe AP
    Mol Biol Rep; 2001; 28(4):209-15. PubMed ID: 12153140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methyl CpG binding proteins: coupling chromatin architecture to gene regulation.
    Wade PA
    Oncogene; 2001 May; 20(24):3166-73. PubMed ID: 11420733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MCAF mediates MBD1-dependent transcriptional repression.
    Fujita N; Watanabe S; Ichimura T; Ohkuma Y; Chiba T; Saya H; Nakao M
    Mol Cell Biol; 2003 Apr; 23(8):2834-43. PubMed ID: 12665582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overlapping roles of the methylated DNA-binding protein MBD1 and polycomb group proteins in transcriptional repression of HOXA genes and heterochromatin foci formation.
    Sakamoto Y; Watanabe S; Ichimura T; Kawasuji M; Koseki H; Baba H; Nakao M
    J Biol Chem; 2007 Jun; 282(22):16391-400. PubMed ID: 17428788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
    Nguyen CT; Gonzales FA; Jones PA
    Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional repression and heterochromatin formation by MBD1 and MCAF/AM family proteins.
    Ichimura T; Watanabe S; Sakamoto Y; Aoto T; Fujita N; Nakao M
    J Biol Chem; 2005 Apr; 280(14):13928-35. PubMed ID: 15691849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin.
    Nan X; Campoy FJ; Bird A
    Cell; 1997 Feb; 88(4):471-81. PubMed ID: 9038338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and characterization of a family of mammalian methyl-CpG binding proteins.
    Hendrich B; Bird A
    Mol Cell Biol; 1998 Nov; 18(11):6538-47. PubMed ID: 9774669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of MBD1-mediated transcriptional repression by SUMO and PIAS proteins.
    Lyst MJ; Nan X; Stancheva I
    EMBO J; 2006 Nov; 25(22):5317-28. PubMed ID: 17066076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solution structure of the methyl-CpG-binding domain of the methylation-dependent transcriptional repressor MBD1.
    Ohki I; Shimotake N; Fujita N; Nakao M; Shirakawa M
    EMBO J; 1999 Dec; 18(23):6653-61. PubMed ID: 10581239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG.
    Klose RJ; Sarraf SA; Schmiedeberg L; McDermott SM; Stancheva I; Bird AP
    Mol Cell; 2005 Sep; 19(5):667-78. PubMed ID: 16137622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The biological functions of the methyl-CpG-binding protein MeCP2 and its implication in Rett syndrome.
    Nan X; Bird A
    Brain Dev; 2001 Dec; 23 Suppl 1():S32-7. PubMed ID: 11738839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Light-Activatable MBD-Readers of 5-Methylcytosine Reveal Domain-Dependent Chromatin Association Kinetics In Vivo.
    Lin TC; Engelhard L; Söldner B; Linser R; Summerer D
    Adv Sci (Weinh); 2024 Mar; 11(11):e2307930. PubMed ID: 38164822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A profile of methyl-CpG binding domain protein occupancy of hypermethylated promoter CpG islands of tumor suppressor genes in human cancer.
    Lopez-Serra L; Ballestar E; Fraga MF; Alaminos M; Setien F; Esteller M
    Cancer Res; 2006 Sep; 66(17):8342-6. PubMed ID: 16951140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.